Evernow has announced a partnership with Clearblue to provide users of the Clearblue Menopause Stage Indicator access to specialized menopause healthcare. The collaboration aims to reach up to 35 million women in menopause transition, offering them a path from at-home testing to professional care.
Users of Clearblue’s Menopause Stage Indicator, launched in August 2023, will be eligible for a one-month free care voucher from Evernow. The test combines urine FSH results with age and cycle history to determine likely menopause stage.
“The (peri)menopause transition often leaves women searching for answers, with many experiencing symptoms for years and seeing multiple doctors before getting proper care,” said Dr. Alicia Jackson, PhD, CEO and Founder of Evernow. “By combining Evernow’s specialized healthcare platform with Clearblue’s innovative at-home testing, we’re creating a clear path from identification and validation of symptoms to care and treatment. By bridging testing clarity with specialized care, we’re removing the traditional barriers that have left millions of women struggling to find effective menopause treatment.”
“At Clearblue, we’re committed to providing women with the knowledge and resources they need to navigate the transitions in their reproductive health,” said Leah Wood, Brand Director at Clearblue. “By joining forces with Evernow, we allow women to get streamlined access to professional care and personalized solutions that empower them to take meaningful steps in their menopause journey.”
The partnership addresses a significant healthcare gap, as 75% of women seeking menopause treatment remain untreated and nearly 80% of medical residents report feeling unprepared to discuss or manage menopause effectively.
Evernow members are matched with menopause-trained healthcare professionals licensed in their state who can explain test results and develop personalized care plans. These may include hormone replacement therapy, weight loss medications, non-hormonal solutions, or lifestyle recommendations. The platform offers care through insurance-covered video visits and unlimited messaging, with ongoing memberships available at $49 per month or as low as $35/month for annual plans.
